Table 2.
Variable | R2 | P value |
---|---|---|
Women (Reference men) | −0.02 | 0.8 |
Non-Caucasians (Reference Caucasians) | −0.02 | 0.7 |
Diabetes mellitus (Reference non-diabetics) | 0.01 | 0.2 |
Cause of kidney disease | −0.03 | 0.6 |
Smoking status | −0.02 | 0.6 |
Body mass index | 0.02 | 0.2 |
Ischemic heart disease | −0.01 | 0.4 |
Congestive heart failure | 0.02 | 0.2 |
Age | 0.01 | 0.2 |
Reticulocyte count | −0.01 | 0.6 |
Total white cell count | −0.02 | 0.8 |
Ferritina | −0.01 | 0.5 |
Transferrin saturationb | −0.01 | 0.6 |
Albumin | 0.001 | 0.3 |
Alkaline phosphatasec | 0.06 | 0.03 |
Gamma-glutamyltransferaseb | 0.01 | 0.2 |
Alanine transaminasec | 0.02 | 0.1 |
Aspartate transaminasec | 0.04 | 0.09 |
Lactate dehydrogenaseb | 0.07 | 0.05 |
Albumin-corrected calcium | 0.05 | 0.06 |
Phosphate | −0.02 | 0.9 |
Parathyroid hormonea | 0.04 | 0.09 |
C-reactive protein | 0.03 | 0.09 |
Total F2-isoprostanesb | −0.01 | 0.5 |
Glutathione peroxidise activityd | −0.004 | 0.9 |
Superoxide dismutase activitye | −0.01 | 0.5 |
Protein carbonylse | −0.03 | 0.9 |
The following non-normally distributed variables were transformed to normality of distribution:
asquare root
blog-transformed
creciprocal of square root
dpower of 3
ereciprocal